Imaging Activated Macrophages in the Lungs
Sponsor: Endocyte
Terminated
Funding has ended and unable to recruit due to COVID 19
Listed as NCT03494114, this PHASE1 trial focuses on COPD and remains terminated or withdrawn. Sponsored by Endocyte, it has been updated 13 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Sep 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Feb 2021 — Sep 2021 [monthly]
Terminated PHASE1
Status: Suspended → Terminated
-
Jan 2021 — Feb 2021 [monthly]
Suspended PHASE1
▶ Show 8 earlier versions
-
Jun 2020 — Jan 2021 [monthly]
Suspended PHASE1
-
May 2020 — Jun 2020 [monthly]
Suspended PHASE1
Status: Enrolling By Invitation → Suspended
-
Mar 2020 — May 2020 [monthly]
Enrolling By Invitation PHASE1
-
Jan 2019 — Mar 2020 [monthly]
Enrolling By Invitation PHASE1
-
Nov 2018 — Jan 2019 [monthly]
Enrolling By Invitation PHASE1
-
Sep 2018 — Nov 2018 [monthly]
Enrolling By Invitation PHASE1
Status: Not Yet Recruiting → Enrolling By Invitation
-
Jun 2018 — Sep 2018 [monthly]
Not Yet Recruiting PHASE1
Phase: PHASE1_PHASE2 → PHASE1
-
May 2018 — Jun 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Endocyte
- Vanderbilt University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .